Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder

NCT02247986 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT02247986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02247986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 1/2
Overall status
Withdrawn
Start date
September 4, 2014
Completion date
May 18, 2015
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

attention defict hyperactivity disorder, conduct disorder